Surveillance for legionnaires' disease: Risk factors for morbidity and mortality

Archives of Internal Medicine

Volumn 154, Issue 21, 1994, Pages 2417-2422

  Marston, Barbara J ^a   Lipman, Harvey B ^b   Breiman, Robert F ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE; ARTICLE; BACTERIUM ISOLATION; FEMALE; GENDER; HEALTH SURVEY; HOSPITAL INFECTION; HUMAN; KIDNEY DISEASE; LEGIONELLA PNEUMOPHILA; LEGIONNAIRE DISEASE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; SEROTYPE; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; HUMANS; LEGIONNAIRES' DISEASE; LOGISTIC MODELS; MALE; MIDDLE AGED; RISK FACTORS; UNITED STATES;

EID: 0028172994     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.154.21.2417     Document Type: Article

References (31)

1. Haley CE, Cohen ML, Halter J, Meyer RD. Nosocomial Legionnaires' disease: a continuing common-source epidemic at Wadsworth Medical Center. Ann Intern Med. 1979;90:583-586.
2. Kirby BD, Snyder KM, Meyer RD, Finegold SM. Legionnaires' disease: report of 65 nosocomially acquired cases and review of the literature. Medicine. 1980; 59:188-204.
3. England AC, Fraser DW, Plikaytis BD, Tsai TF, Storch G, Broome CV. Sporadic legionellosis in the United States: the first thousand cases. Ann Intern Med. 1981;94:164-170.
4. Friede A, Reid JA, Ory HW. WONDER: CDC's Online Public Health Information System. Atlanta, Ga: US Dept of Health and Human Services, Public Health Service, Centers for Disease Control; 1990.
5. Feldman AR, Kessler L, Myers MH, Naughton MD. The prevalence of cancer: estimates based on the Connecticut Tumor Registry. N Engl J Med. 1986;315: 1394-1397.
6. Eggers PW, Connerton R, McMullan M. The Medicare experience with endstage renal disease: trends in incidence, prevalence, and survival. Health Care Finance Rev. 1984;5:69-88.
7. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report. Atlanta, Ga: Centers for Disease Control and Prevention; 1992:1-22.
8. Kleinbaum D, Kupper L, Morgenstern H. Epidemiologic Research: Principles and Quantitative Methods. Belmont, Calif: Lifetime Learning Publications; 1982.
9. Portmore AC, Graman PS. Five cases of Legionella pneumophila in patients with advanced HIV disease. Abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy; October 11-14, 1992; Anaheim, Calif. Abstract No. A374.
10. Allam AA, Kamholz SL. Legionella pneumonia and AIDS. Chest. 1989;95:707-708.
11. Johnson JT, Best MG, Goetz A, Sicker H, Yu V, Vickers RM. Nosocomial legionellosis in surgical patients with head-and-neck cancer: implications for epidemiological reservoir and mode of transmission. Lancet. 1985;2:298-300.
12. Fallon RJ, Abraham WH. Legionnaires' disease: serogroup 6. Lancet. 1980;2: 857-858.
13. Dowling JN, Saha AK, Glew RH. Virulence factors of the family Legionellaceae. Microbiol Rev. 1992;56:32-60.
14. Fields BS, Barbaree JM, Shotts EBJ, Feeley JC, Morrill WE, Sanden GN. Comparison of guinea pig and protozoan models for determining virulence of Legionella species. Infect Immun. 1986;53:553-559.
15. Bollin GE, Plouffe JF, Para MF, Prior RB. Difference in virulence of environmental isolates of Legionella pneumophila. J Clin Microbiol. 1985;21:674-677.
16. Dennis PJ, Lee JV. Differences in aerosol survival between pathogenic and non-pathogenic strains of Legionella pneumophila serogroup 1. J Appl Bacteriol. 1988;65:135-141.
17. Summersgill JT, Raff MJ, Miller RD. Interactions of virulent and avirulent Legionella pneumophila with human monocytes. J Leuk Biol. 1990;47:31-38.
18. Reingold AL, Thomason BM, Brake BJ, Thacker L, Wilkinson HW, Kuritsky JN. Legionella pneumonia in the United States: the distribution of serogroups and species causing human illness. J Infect Dis. 1984;149:819.
19. Aguero-Rosenfeld ME, Edelstein PH. Retrospective evaluation of the Du Pont radioimmunoassay kit for detection of Legionella pneumophila serogroup 1 antigenuria in humans. J Clin Microbiol. 1988;26:1775-1778.
20. Birtles RJ, Harrison TG, Samuel D, Taylor AG. Evaluation of urinary antigen ELISA for diagnosing Legionella pneumophila serogroup 1 infection. J Clin Pathol. 1990;43:685-690.
21. Kohler RB, Wheat LJ, French MLV, Meenhorst PL, Winn WC, Edelstein PH. Cross-reactive urinary antigens among patients infected with Legionella pneumophila serogroups 1 and 4 and the Leiden 1 strain. J Infect Dis. 1985;152: 1007-1012.
22. Tang PW, Toma S. Broad-spectrum enzyme-linked immunosorbent assay for detection of Legionella soluble antigens. J Clin Microbiol. 1986;24:556-558.
23. Tang P, Krishnan C. Legionella antigenuria: 6-year study of broad-spectrum enzyme-linked immunosorbent assay as a routine diagnostic test. In: Barbaree J, Breiman RF, Dufour A, eds. Legionella, Current Status and Emerging Perspectives. Washington, DC: American Society for Microbiology; 1993:12-13.
24. Ruf B, Schurmann D, Horbach I, Fehrenbach FJ, Pohle HD. Prevalence and diagnosis of Legionella pneumonia: a 3-year prospective study with emphasis on application of urinary antigen detection. J Infect Dis. 1990;162:1341-1348.
25. Fang GD, Fine M, Orloff J, Arisumi D, Yu VL, Kapoor W. New and emerging etiologies for community-acquired pneumonia with implications for therapy: a prospective multicenter study of 359 cases. Medicine. 1990;69:307-316.
26. Inpatient utilization of short-stay hospitals by diagnosis. In: US 1982 Annual Summary. Washington, DC: National Center for Health Statistics, US Dept of Health and Human Services; 1983. Series 13, No. 72 (PHS-83-1733).
27. Statistical Abstract of the US. 108th ed. Washington, DC: US Dept of Commerce, Bureau of Census; 1988.
28. Marston BJ, Plouffe JF, Breiman RF, et al. Preliminary findings of a communitybased pneumonia incidence study. In: Barbaree J, Breiman RF, Dufour A, eds. Legionella, Current Status and Emerging Perspectives. Washington, DC: American Society for Microbiology; 1993:36-37.
29. Centers for Disease Control. Summary of notifiable diseases: United States, 1990. MMWR Morb Mortal Wkly Rep. 1990;39:55.
30. Blander SJ, Horwitz MA. Vaccination with the major secretory protein of Legionella pneumophila induces cell-mediated and protective immunity in a guinea pig model of Legionnaires' disease. J Exp Med. 1989;169:691-705.
31. Horwitz MA. Prospects for vaccine development. In: Barbaree J, Breiman RF, Dufour A, eds. Legionella, Current Status and Emerging Perspectives. Washington, DC: American Society for Microbiology; 1993:294-297.